ICM
CRI icon

Invenomic Capital Management’s Carter's CRI Stock Holding History

Invenomic Capital Management’s Portfolio CRI Stock Details CRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,369
Closed -$287K – 161
2020
Q1 		$287K Buy
+4,369
New +$420K 0.23% 102

Other funds holding CRI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Invenomic Capital Management's CRI Position: Q2 2020 in Review

Invenomic Capital Management sold out of Carter's (CRI) in Q2 2020, closing a stake of 4,369 shares — an estimated $287K sold.

Invenomic Capital Management first reported a position in CRI in Q1 2020 and held it in 1 quarter. The position peaked at $287K in Q1 2020. 302 funds tracked by Wall St. Rank hold CRI as of Q2 2020.

  • Invenomic Capital Management reported no remaining Carter's position as of Q2 2020 after selling out during the quarter.
  • Invenomic Capital Management sold 4,369 Carter's shares in Q2 2020, an estimated $287K.
  • Invenomic Capital Management first reported a position in Carter's in Q1 2020 and held it in 1 quarter.
  • Invenomic Capital Management's Carter's position peaked at $287K in Q1 2020.
  • 302 funds tracked by Wall St. Rank held Carter's as of Q2 2020.

Based on Invenomic Capital Management's 13F filing for Q2 2020, filed 13 Aug 2020.